2026, Number 1
Direct healthcare costs for cases of sars-cov-2 infection during 2024 in neonatal patients receiving minimal intervention therapy at the National Institute of Perinatology
Galván-Contreras R, Santamaría-Alonso I, Calva-Hernández JV, Arellano-Flores MX, Trinidad-Muñoz AS, Segura-Cervantes , Luna-Gordillo R, Solórzano-Santos F
Full text
Language: Spanish
References: 6
Page: 14-20
PDF size: 283.90 Kb.
ABSTRACT
Introduction. Neonates are a highly vulnerable population to respiratory infections such as sars-cov-2. This study aims to quantify the economic impact of covid-19 outbreaks in the neonatal minimal intervention therapy unit (timn) of the National Institute of Perinatology during 2024.Methods. A retrospective observational study was conducted to analyze direct healthcare costs associated with 34 confirmed sars-cov-2 infection cases (via rt-pcr) in neonates hospitalized at timn between January and December 2024. A control group of 34 neonates without sars-cov-2 infection was selected for comparison.
Results. Infected neonates showed significantly higher healthcare costs, especially in laboratory testing, imaging, and length of hospital stay (mean: 18.5 days vs. 5.3 days in controls, p < 0.001). The total cost for infected cases was 99,620.60 pesos vs. 35,906.00 pesos for controls.
Conclusions. sars-cov-2 infection in neonates hospitalized at timn significantly increases direct healthcare costs, mainly due to longer hospital stays and additional diagnostics. These findings support the implementation of cost-effective preventive strategies in vulnerable hospital settings.
REFERENCES
De Rose, D.U., Pugnaloni, F., Calì, M., Ronci, S., Caoci,S., Maddaloni, C. et al., “Multisystem inflammatorysyndrome in neonates born to mothers with sars-cov-2infection (mis-n) and in neonates and infants youngerthan 6 months with acquired covid-19 (mis-c): a systematicreview”, mdpi Viruses, 2022. Disponible en: https://www.mdpi.com/1999-4915/14/4/750.